Clinical Trials Directory

Trials / Completed

CompletedNCT03652116

Bupivacaine Verus Pethidine for Post Cesarean Section Pain Relief

Subrectal and Subcutaneous Wound Infiltration With Bupivacaine Versus Pethidine for Postcesarean Section Pain Relief: a Randomized Clinical Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
78 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to compare between the effect of wound infiltration with bupivacaine or pethidine for post cesarean section pain relief.

Conditions

Interventions

TypeNameDescription
DRUGWound infiltration by BupivacaineSubcutaneous and subrectal infiltration with 0.25 % Bupivacaine diluted in 20 ml normal saline before closure of the wound
DRUGWound infiltration by PethidineSubcutaneous and subrectal infiltration with 50 mg pethidine diluted in 20 ml normal saline before closure of the wound

Timeline

Start date
2017-04-21
Primary completion
2018-06-10
Completion
2018-08-01
First posted
2018-08-29
Last updated
2018-08-31

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03652116. Inclusion in this directory is not an endorsement.

Bupivacaine Verus Pethidine for Post Cesarean Section Pain Relief (NCT03652116) · Clinical Trials Directory